Publications by authors named "Joshua D Hessler"

Claim this Profile
I
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Jason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, Jennifer A Woyach, Samantha Jaglowski, Joshua D Hessler

Blood· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells.
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, Joshua D Hessler, Xiaoli Zhang

Blood· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis